These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6698658)

  • 21. [Biopharmaceutic investigations with D-norpseudoephedrine (author's transl)].
    Frosch F
    Arzneimittelforschung; 1977; 27(3):665-8. PubMed ID: 577442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation].
    Pirovino M; Karlaganis G; Galeazzi RL
    Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity.
    Brynne N; Stahl MM; Hallén B; Edlund PO; Palmér L; Höglund P; Gabrielsson J
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):287-95. PubMed ID: 9247842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
    Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
    J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.
    Rasmussen SN; Bondesen S; Hvidberg EF; Hansen SH; Binder V; Halskov S; Flachs H
    Gastroenterology; 1982 Nov; 83(5):1062-70. PubMed ID: 7117789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
    Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G
    J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects.
    Scherzinger SS; Dowse R; Kanfer I
    J Clin Pharmacol; 1990 Apr; 30(4):372-7. PubMed ID: 2341583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microencapsulation of phenylpropanolamine to achieve sustained release.
    Prapaitrakul W; Whitworth CW
    J Microencapsul; 1989; 6(2):213-8. PubMed ID: 2723965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and cardiovascular safety of Dexatrim (phenylpropanolamine hydrochloride) from a controlled-release caplet.
    Shargel L; Silverman HI; Cohen P; Brisson J; Dennis S
    Biopharm Drug Dispos; 1990 Oct; 11(7):569-83. PubMed ID: 2265237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lithium balance in healthy volunteers].
    Consbruch U; Degkwitz R; Koufen H
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):228-34. PubMed ID: 704664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of phenylpropanolamine in serum and urine by high-performance liquid chromatography.
    Dowse R; Haigh JM; Kanfer I
    J Pharm Sci; 1983 Sep; 72(9):1018-20. PubMed ID: 6631684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma levels, renal excretion and metabolism of orciprenaline after administration in sustained-release form (author's transl)].
    Gilfrich HJ; Ober KF; Förster HJ; Rominger KL
    Arzneimittelforschung; 1979; 29(6):967-70. PubMed ID: 582794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels and urinary excretion of verapamil, norverapamil, N-dealkylverapamil (D617), N-dealkylnorverapamil (D620) following oral administration of a slow-release preparation.
    Barbieri E; Padrini R; Piovan D; Toffoli M; Cargnelli G; Trevi G; Ferrari M
    Int J Clin Pharmacol Res; 1985; 5(2):99-107. PubMed ID: 4018947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concentration of 14C-1-butylbiguanide in plasma of diabetic patients and its elimination after administration of a new Galenical formulation (author's transl)].
    Gutsche H; Blumenbach L; Losert W; Wiemann H
    Arzneimittelforschung; 1976; 26(6):1227-9. PubMed ID: 989423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative determination and kinetics of dihydralazine in hypertension patients].
    Siegmund W; Zschiesche M; Kallwellis R; Franke G; Schneider T; Sill U; Scherber A; Hüller H
    Pharmazie; 1985 Nov; 40(11):779-81. PubMed ID: 4095128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.
    Hussain MA; Aungst BJ; Lam G; Shefter E
    Biopharm Drug Dispos; 1987; 8(5):497-505. PubMed ID: 3663885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electron-capture capillary gas chromatographic determination of phenylpropanolamine in human plasma following derivatization with trifluoroacetic anhydride.
    Crisologo N; Dye D; Bayne WF
    J Pharm Sci; 1984 Sep; 73(9):1313-5. PubMed ID: 6491962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.